These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19505824)

  • 1. Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.
    Bonjoch J; Diaba F; Pagès L; Pérez D; Soca L; Miralpeix M; Vilella D; Anton P; Puig C
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4299-302. PubMed ID: 19505824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cytotoxic activities of 1-benzylidine substituted beta-carboline derivatives.
    Cao R; Yi W; Wu Q; Guan X; Feng M; Ma C; Chen Z; Song H; Peng W
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6558-61. PubMed ID: 18952426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
    Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
    Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore identification, synthesis, and biological evaluation of carboxylated chalcone derivatives as CysLT1 antagonists.
    Dong X; Wang L; Huang X; Liu T; Wei E; Du L; Yang B; Hu Y
    Bioorg Med Chem; 2010 Aug; 18(15):5519-27. PubMed ID: 20621485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Okun IM; Tkachenko SE
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3183-7. PubMed ID: 19443217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
    Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1.
    Westaway SM; Thompson M; Rami HK; Stemp G; Trouw LS; Mitchell DJ; Seal JT; Medhurst SJ; Lappin SC; Biggs J; Wright J; Arpino S; Jerman JC; Cryan JE; Holland V; Winborn KY; Coleman T; Stevens AJ; Davis JB; Gunthorpe MJ
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5609-13. PubMed ID: 18809327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles.
    McAtee JJ; Dodson JW; Dowdell SE; Erhard K; Girard GR; Goodman KB; Hilfiker MA; Jin J; Sehon CA; Sha D; Shi D; Wang F; Wang GZ; Wang N; Wang Y; Viet AQ; Yuan CC; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3716-9. PubMed ID: 18524591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors.
    Cheung M; Harris PA; Badiang JG; Peckham GE; Chamberlain SD; Alberti MJ; Jung DK; Harris SS; Bramson NH; Epperly AH; Stimpson SA; Peel MR
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5428-30. PubMed ID: 18818075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists.
    Sato N; Jitsuoka M; Ishikawa S; Nagai K; Tsuge H; Ando M; Okamoto O; Iwaasa H; Gomori A; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1670-4. PubMed ID: 19233647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
    Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiro-piperidine azetidinones as potent TRPV1 antagonists.
    Xiao D; Palani A; Aslanian R; McKittrick BA; McPhail AT; Correll CC; Phelps PT; Anthes JC; Rindgen D
    Bioorg Med Chem Lett; 2009 Feb; 19(3):783-7. PubMed ID: 19114307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonists.
    Paliwal S; Reichard GA; Shah S; Wrobleski ML; Wang C; Stengone C; Tsui HC; Xiao D; Duffy RA; Lachowicz JE; Nomeir AA; Varty GB; Shih NY
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4168-71. PubMed ID: 18547807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
    Jin J; Wang Y; Shi D; Wang F; Fu W; Davis RS; Jin Q; Foley JJ; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5481-6. PubMed ID: 18818072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro anti-inflammatory and cytotoxic evaluation, and mechanism of action studies of 1-benzoyl-β-carboline and 1-benzoyl-3-carboxy-β-carboline derivatives.
    Yang ML; Kuo PC; Hwang TL; Chiou WF; Qian K; Lai CY; Lee KH; Wu TS
    Bioorg Med Chem; 2011 Mar; 19(5):1674-82. PubMed ID: 21316977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
    Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
    Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
    Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
    Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
    Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
    Kim DK; Lim JH; Lee JA; Dewang PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.